Literature DB >> 961953

Racial difference in incidence of ABO hemolytic disease.

K A Bucher, A M Patterson, R C Elston, C A Jones, H N Kirkman.   

Abstract

In this review of 7,464 consecutive infants born at North Carolina Memorial Hospital, hemolytic disease from ABO incompatibility was found to be two to three times as common in black infants as in white infants. The statistical significance of the difference remained high as more restrictive criteria for ABO hemolytic disease were applied. ABO disease, serious enough to cause an indirect serum bilirubin of 15 mg/100ml or higher, had an incidence in black newborns as great as the incidence of Rh hemolytic disease in whites. In contrast, the general prevalence and severity of hyperbilirubinemia was not found to be higher in black newborns than in white infants. The difference cannot be attributed to differences in the prevalence of ABO blood groups between the two races. Policies of early discharge of newborns could be affected by the finding that ABO erythroblastosis is two to three times as common in black infants as in white infants.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961953      PMCID: PMC1653477          DOI: 10.2105/ajph.66.9.854

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  8 in total

1.  ABO heterospecific pregnancy and hemolytic disease; a study of normal and pathologic variants. IV. Pathologic variants.

Authors:  W W ZUELZER; E KAPLAN
Journal:  AMA Am J Dis Child       Date:  1954-09

2.  ABO system incompatibility: relationship between direct Coombs test positivity and neonatal jaundice.

Authors:  M Orzalesi; F Gloria; P Lucarelli; E Bottini
Journal:  Pediatrics       Date:  1973-02       Impact factor: 7.124

3.  Site of lesion in cases of hearing loss associated with Rh incompatibility: an argument for peripheral impairment.

Authors:  R Goldstein; C C McRandle; L B Rodman
Journal:  J Speech Hear Disord       Date:  1972-11

4.  CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients.

Authors:  C B Hyman; J Keaster; V Hanson; I Harris; R Sedgwick; H Wursten; A R Wright
Journal:  Am J Dis Child       Date:  1969-04

5.  Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility.

Authors:  T R Sisson; N Kendall; S C Glauser; S Knutson; E Bunyaviroch
Journal:  J Pediatr       Date:  1971-12       Impact factor: 4.406

6.  "Haemolytic" jaundice of the newborn (not Rh) in paediatric wards of general hospitals.

Authors:  F J Ford
Journal:  S Afr Med J       Date:  1969-12-13

7.  A laboratory survey of A-B-O blood-group incompatibility and neonatal jaundice.

Authors:  S Brink
Journal:  S Afr Med J       Date:  1969-08-23

8.  A-B-O incompatibility and haemolytic disease of the newborn.

Authors:  A G Farrell
Journal:  S Afr Med J       Date:  1970-02-21
  8 in total
  4 in total

1.  Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.

Authors:  Ramesh Y Bhat; Pavan C G Kumar
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

2.  Editorial: Radical inequality and neonatal jaundice.

Authors:  L K Diamond
Journal:  Am J Public Health       Date:  1976-09       Impact factor: 9.308

3.  Maternal Blood Group and Routine Direct Antiglobulin Testing in Neonates: Is There a Role for Selective Neonatal Testing?

Authors:  Hwazen A Shash; Suzan A Alkhater
Journal:  Children (Basel)       Date:  2021-05-20

4.  Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos.

Authors:  Alani Sulaimon Akanmu; Olufemi Abiola Oyedeji; Titilope Adenike Adeyemo; Ann Abiola Ogbenna
Journal:  J Blood Transfus       Date:  2015-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.